Copyright © Inderes 2011 - present. All rights reserved.
Log in to your Inderes Free account to see all free content on this page.
Create account

Surgical Science Sweden

24.74 SEK

-1.20 %

Less than 1K followers

SUS

First North Stockholm

Medical Equipment & Services

Health Care

-1.20 %
-19.15 %
-23.88 %
-66.11 %
-74.86 %
-86.94 %
-83.86 %
-80.82 %
+115.13 %

Surgical Science Sweden operates in the medical technology sector. The company develops VR simulators in surgery. The simulators consist of both hardware and software that are used in training and personal development for surgeons. The hardware simulates various surgical procedures, primarily used in keyhole surgery and endoscopy. The vision is to strengthen expertise in surgery and create conditions for better treatments. The headquarters are located in Gothenburg.

Read more
Market cap
1.26B SEK
Turnover
5.43M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
19.2.
2026

Annual report '25

20.5.
2026

Interim report Q1'26

21.5.
2026

General meeting '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Forum discussions
Pareto Securities expects a double-digit decline for surgical simulator company Surgical Science after customer Intuitive terminated its letter of intent to integrate the company’s simulation software into all da Vinci 5 (dV5) robotic systems. According to Surgical Science, this ...
11/26/2025, 7:56 AM
by timontti
7
Now there’s a spanner in the works. Intuitive is withdrawing from the memorandum of understanding drafted in January. Consequently, SUS’s simulation software will no longer be included in every delivery of the Da Vinci 5 model, but only for selected customers. As a result, next year...
11/25/2025, 11:48 PM
by Marmoset
6
Q3, perhaps a step in the right direction even though profitability is still under pressure. CMD next month. MFN – 13 Nov 25 Surgical Science Sweden AB (publ): Interim report January–Septemb... Third quarter 2025 (July – September) Net sales amounted to SEK 263.6 (231.8) million,...
11/13/2025, 7:20 AM
by sillinkutoja
3
I’m not entirely sure what opinion you ended up with on this, but at least ISRG sees some sense in it. Largest customer Intuitive Surgical will roll out its cutting-edge da Vinci 5 surgical robot in 2025e and include simulation in all systems, increasing attach rate from c30-35% ...
10/22/2025, 6:37 AM
by timontti
3
Surgical Science Sweden’s Q3’25 webcast: Inderes Surgical Science Sweden, Audiocast, Q3'25 - Inderes Time: 2025-11-13 11:00 Language: en Language: en Sector: Health care - Equipment & Services Activity: Audiocast with teleconference
11/13/2025, 1:23 PM
by Isa Hudd
2
Intuitive’s sales figures are interesting because ISRG is Surgical Science’s largest customer, and the companies have collaborated for a long time. At least as part of every Da Vinci 5 surgical robot sold by ISRG, Surgical Science’s developed simulation and training software is delivered...
10/21/2025, 10:27 PM
by Marmoset
2
SURGICAL SCIENCE: DANSKE SEES INTERESTING GROWTH PROSPECTS DESPITE DOWNSlide STOCKHOLM (Nyhetsbyrån Direkt) Danske Bank continues to believe that Surgical Science has interesting growth prospects despite the terminated letter of intent with Intuitive Surgical (ISRG) that was announced...
11/27/2025, 7:45 AM
by timontti
1
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.